Product NDC: | 23155-005 |
Proprietary Name: | Sulindac |
Non Proprietary Name: | Sulindac |
Active Ingredient(s): | 150 mg/1 & nbsp; Sulindac |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 23155-005 |
Labeler Name: | Heritage Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA073262 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070716 |
Package NDC: | 23155-005-05 |
Package Description: | 500 TABLET in 1 BOTTLE (23155-005-05) |
NDC Code | 23155-005-05 |
Proprietary Name | Sulindac |
Package Description | 500 TABLET in 1 BOTTLE (23155-005-05) |
Product NDC | 23155-005 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Sulindac |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20070716 |
Marketing Category Name | ANDA |
Labeler Name | Heritage Pharmaceuticals Inc. |
Substance Name | SULINDAC |
Strength Number | 150 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |